Quick answer: It depends on your state and your diagnosis. Every state Medicaid program covers GLP-1 medications like semaglutide and tirzepatide when they are prescribed for type 2 diabetes. Only a minority of states, 13 as of January 2026, cover these drugs for obesity or weight loss on their own, and that number has been falling as states cut costs. Federal law does not require states to cover weight-loss drugs, so coverage is a patchwork.
If you have Medicaid and want a GLP-1 for weight loss, the single biggest factor is whether the prescription is written for diabetes or for obesity. This guide explains the federal rule, how state coverage differs, what prior authorization involves, and what to do if you are denied. This is general education, not medical or legal advice.
Are weight loss drugs covered by Medicaid?
Sometimes. Federal Medicaid law lets states exclude drugs used for weight loss. Section 1927(d)(2) of the Social Security Act lists "agents when used for anorexia, weight loss, or weight gain" among the categories states are not required to cover. That rule dates to 1993, long before GLP-1 drugs existed, and it was aimed at older appetite suppressants.
The result is that each state decides on its own. Most states do not cover GLP-1 drugs for obesity alone. A minority do, with restrictions. The same drugs are covered for type 2 diabetes in every state, because coverage for diabetes, cardiovascular disease, and sleep apnea indications is required of state Medicaid programs, while obesity coverage is optional.
Does Medicaid cover any weight loss drugs?
Yes, in the states that have chosen to. Per KFF tracking, 13 state Medicaid programs covered GLP-1 medications for obesity under fee-for-service as of January 2026. That is down from 16 in October 2025, after California, New Hampshire, Pennsylvania, and South Carolina ended obesity coverage under budget pressure. In the states that still cover it, coverage almost always requires prior authorization and specific clinical criteria. In the other states, Medicaid will pay for a GLP-1 only when it is prescribed for an approved use other than weight loss, which in practice means diabetes, established cardiovascular disease, or sleep apnea.
Does Medicaid cover Ozempic, Mounjaro, Wegovy, and Zepbound?
The pattern follows the indication, not the brand.
See transparent compounded pricing
Review compounded GLP-1 pricing and what provider-reviewed care includes, with no surprises at checkout.
Try the Cost Calculator →| Drug | Indication | Medicaid coverage pattern |
|---|---|---|
| Ozempic (semaglutide) | Type 2 diabetes | Covered in all states for diabetes, with prior authorization |
| Mounjaro (tirzepatide) | Type 2 diabetes | Covered in all states for diabetes, with prior authorization |
| Wegovy (semaglutide) | Chronic weight management | Covered for obesity only in the minority of states that opted in |
| Zepbound (tirzepatide) | Chronic weight management | Covered for obesity only in the states that opted in |
Ozempic and Mounjaro are diabetes products. Wegovy and Zepbound are the weight-management products. A veteran-style coverage split applies: the diabetes labels open the door in every state, while the obesity labels depend on whether your state covers anti-obesity drugs.
Does Medicaid cover Ozempic for weight loss?
Medicaid covers Ozempic when it is prescribed for type 2 diabetes. If a provider prescribes Ozempic for weight loss in someone without diabetes, most state programs deny it. Some clinicians treat patients who have both prediabetes and obesity under a diabetes-prevention rationale, which is a clinical judgment call your provider has to make and document. Intentionally miscoding a diagnosis to obtain coverage is not allowed.
Does Medicaid cover Mounjaro for weight loss?
Mounjaro is covered for type 2 diabetes in all states, with prior authorization. Mounjaro is not approved for weight loss, so a request framed around obesity is generally denied. The weight-management version of tirzepatide is Zepbound, which only the opt-in states cover.
State examples: NY, Texas, Michigan, Illinois, Indiana, Iowa, Colorado, NJ, SC
Coverage and criteria change often, so treat these as starting points and confirm with your state formulary.
- New York, New Jersey, Illinois, and Colorado: Among the states that cover anti-obesity GLP-1s with prior authorization and BMI-based criteria. All states, including these, cover GLP-1s for diabetes.
- Texas, Michigan, Indiana, and Iowa: Generally cover GLP-1s for diabetes but not for obesity alone, so weight-loss-only requests are typically denied.
- South Carolina: Previously covered obesity GLP-1s but ended that coverage in late 2025, so it now covers GLP-1s for diabetes only.
Because the roster is shifting and several states cut obesity coverage in late 2025, the reliable move is to check your state's current preferred drug list rather than rely on any static list.
Does Medicaid pay for weight loss injections or shots in your state?
If your state is one that covers anti-obesity GLP-1s, then yes, the injectable is covered with prior authorization. If your state covers GLP-1s only for diabetes, the injection is covered for diabetes but not for weight loss on its own. There is no separate income test for weight-loss drug coverage beyond standard Medicaid eligibility.
What does prior authorization involve?
In states that cover anti-obesity medication, prior authorization usually asks your provider to document:
- A qualifying BMI, often 30 or higher, or 27 or higher with a weight-related condition
- At least one obesity-related condition such as hypertension, high cholesterol, sleep apnea, or fatty liver disease
- A prior attempt at lifestyle change, and sometimes a trial of a lower-cost medication first
- Ongoing follow-up showing weight loss to continue coverage
Review timelines and approval odds vary by state and by how completely the request is documented.
Does Medicaid cover compounded semaglutide?
No. Medicaid formularies pay for FDA-approved drugs. Compounded semaglutide is not FDA-approved, so it is not reimbursed by Medicaid and must be paid out of pocket if you choose it. Compounded medications are prepared by a state-licensed pharmacy in response to an individual prescription and have not gone through FDA approval.
What if Medicaid denies you?
You have options. Ask your provider to resubmit with stronger documentation, since many denials come from incomplete paperwork. File a formal appeal if you meet the criteria. Check whether the diabetes pathway fits your clinical situation. If you have type 2 diabetes or documented prediabetes, that pathway may be open in your state.
Note that manufacturer patient-assistance programs from Novo Nordisk and Eli Lilly generally exclude people enrolled in Medicaid or other government coverage, because of federal anti-kickback rules. That leaves cash-pay brand-name drugs or cash-pay compounded options for people whose Medicaid will not cover weight-loss treatment.
If weight loss is your goal and you are weighing routes, you can review medically supervised options for compounded semaglutide or compare your choices with the provider comparison tool. Coverage decisions still rest with your state Medicaid program and your prescriber.
How to verify your state's coverage
Search for "[your state] Medicaid preferred drug list" and look for semaglutide, Ozempic, Wegovy, tirzepatide, Mounjaro, and Zepbound. Note any flags for prior authorization, quantity limits, or step therapy. Then find your state's prior authorization criteria document for the exact BMI and comorbidity rules. If you are in managed care, call the member-services number on your card and ask directly whether your plan covers Wegovy or Zepbound for obesity and what the criteria are.
Frequently asked questions
Are weight loss drugs covered by Medicaid? Only in the states that chose to cover them for obesity, 13 as of January 2026, a number that has been falling. All states cover GLP-1s for type 2 diabetes. Federal law does not require weight-loss drug coverage.
Does Medicaid cover GLP-1 in NY? New York Medicaid covers GLP-1s for diabetes statewide and has moved toward covering anti-obesity GLP-1s with prior authorization. Confirm current criteria with the NY formulary.
Does Indiana, Iowa, Texas, Michigan, or SC Medicaid cover weight loss medication? These states cover GLP-1s for diabetes but not for obesity alone. South Carolina ended its obesity coverage in late 2025. Weight-loss-only requests are typically denied. Verify with each state's current formulary.
Does Medicaid cover Mounjaro or Zepbound for weight loss? Mounjaro is covered for diabetes in all states. Zepbound, the weight-management tirzepatide, is covered only in the states that opted into anti-obesity coverage.
Does Medicaid pay for weight loss injections in Texas? Texas Medicaid covers GLP-1 injections for diabetes but not for weight loss on its own, so an obesity-only request is generally denied.
Can I get Wegovy free if I have Medicaid? In states that cover it, you pay a small specialty-tier copay. In states that do not, Medicaid will not cover Wegovy, and government-coverage rules exclude you from manufacturer assistance programs.
Does Medicaid cover compounded semaglutide? No. Compounded semaglutide is not FDA-approved and is not on Medicaid formularies, so it is paid out of pocket.
Does Medi-Weight Loss accept Medicaid? Commercial weight-loss clinics set their own payment policies and many do not bill Medicaid. Confirm directly with the clinic.
Sources
- Medicaid Coverage of and Spending on GLP-1s. KFF, 2025-2026. https://www.kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s/
- States retreat from covering drugs for weight loss. Stateline, November 2025. https://stateline.org/2025/11/28/states-retreat-from-covering-drugs-for-weight-loss/
- Social Security Act Section 1927(d)(2), limitations on coverage of drugs. https://www.ssa.gov/OP_Home/ssact/title19/1927.htm
- Centers for Medicare and Medicaid Services, Medicaid prescription drugs. https://www.medicaid.gov/medicaid/prescription-drugs/index.html
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →